Kura Oncology, Inc. - KURA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | Chief Financial Officer | A | A | 450,000.0 | 0.0 | 0.0 | 450,000.0 | View | |
| Aug 24, 2026 | President and CEO | P | A | 100,000.0 | 12.39 | 1,239,000.0 | 479,194.0 | View | |
| Aug 24, 2026 | Chief Commercial Officer | S | D | 4,345.0 | 11.8903 | 51,663.35 | 169,269.0 | View | |
| Aug 21, 2026 | Chief Legal Officer | S | D | 31,487.0 | 12.63 | 397,680.81 | 195,444.0 | View | |
| Aug 17, 2026 | President and CEO | P | A | 100,000.0 | 11.12 | 1,112,000.0 | 379,194.0 | View | |
| Jun 22, 2026 | Chief Medical Officer | S | D | 84,929.0 | 9.8233 | 834,283.05 | 182,345.0 | View | |
| Jun 04, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| Jun 04, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| Jun 04, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| Jun 04, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| Jun 04, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| Jun 04, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| Jun 04, 2026 | — | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| May 22, 2026 | Chief Commercial Officer | S | D | 10,000.0 | 11.0 | 110,000.0 | 173,614.0 | View | |
| May 20, 2026 | Chief Operating Officer | S | D | 2,257.0 | 9.0752 | 20,482.73 | 153,560.0 | View | |
| May 20, 2026 | Chief Commercial Officer | S | D | 339.0 | 9.21 | 3,122.19 | 183,614.0 | View | |
| May 20, 2026 | Chief Legal Officer | S | D | 2,256.0 | 9.3795 | 21,160.15 | 226,931.0 | View |